-
公开(公告)号:US20220192240A1
公开(公告)日:2022-06-23
申请号:US17603194
申请日:2019-04-11
申请人: Sami ALSHEHRI
发明人: Sami ALSHEHRI
摘要: The invention is related to a processes for producing a new food product of dates free of the glucose, wherein the process of removing the sugars from dates comprises contacting or submerging the dates with a healed water solution, wherein the solution including sodium chloride to remove the sugars from the date fibers; treating the dates fiber by adding food additives such as food coloring, and antioxidants by inhibiting the degradation of food by oxygen.
-
公开(公告)号:US11199543B2
公开(公告)日:2021-12-14
申请号:US16365740
申请日:2019-03-27
IPC分类号: A61K31/00 , G01N33/569 , G01N33/68 , A23L33/20
摘要: Disclosed are methods of diagnosing and treating a subject with active or inactive eosinophilic esophagitis (EoE). The methods may include the steps of detecting whether a level of eosinophil lineage-committed progenitor (EoP) is elevated in a blood sample obtained from a subject, diagnosing the subject with active EoE when an EoP level in the sample is elevated above a pre-determined cut-off value and diagnosing the subject with inactive EoE when the EoP level in the sample is below a pre-determined cut-off value; and treating the subject diagnosed with active EoE. Kits related to same are also disclosed.
-
公开(公告)号:US20210298341A1
公开(公告)日:2021-09-30
申请号:US17266247
申请日:2018-08-10
申请人: SAMYANG CORPORATION
发明人: Tae-Chul HAN , Hye Jin LIM , Bong Chan KIM , Yong-In KIM , ll SEO , Seung Mi LEE
IPC分类号: A23L33/20 , A23L2/58 , A23L2/60 , A23L33/125 , A23L33/15
摘要: The present invention relates to a nutritional drink containing allulose and vitamins, and has excellent storage stability and sensory properties depending on the use of allulose.
-
公开(公告)号:US20210244695A1
公开(公告)日:2021-08-12
申请号:US17240605
申请日:2021-04-26
IPC分类号: A61K31/194 , A61P13/12 , A23L33/20 , A61K31/047
摘要: Compositions and methods for supporting health, especially renal health, comprising ketonic agents that recapitulate beneficial effects of ketosis by exogenously administered agents. The agents include BHB, analogs thereof, and GPR109A agonists. The agents may further include crystal precipitation inhibitors which synergistically improve treatment of certain renal conditions. The agents may be used in dietary supplements and therapeutic compositions for the treatment of cystic kidney diseases such as polycystic kidney disease, ciliopathies, and other conditions.
-
公开(公告)号:US20210161168A1
公开(公告)日:2021-06-03
申请号:US16496566
申请日:2019-02-01
摘要: The present invention provides the use of a composition obtainable from the pulp of a plant in the theobroma genus or an extract of said pulp, as an ingredient in a chocolate product.
-
公开(公告)号:US10945446B2
公开(公告)日:2021-03-16
申请号:US16776777
申请日:2020-01-30
发明人: Zihua Ao , Carol Lynn Berseth , Patricia Cobb , Juan M. Gonzalez , Elisha London , Minhthy Nguyen , James David Richards , Colin Rudolph , John D. Alvey , Yadilka Maldonado , Chenzhong Kuang , Yan Xiao , Dirk Hondmann
IPC分类号: A23C17/00 , A61K35/20 , A61K31/202 , A61K31/715 , A61K31/702 , A61K38/48 , A61K31/7004 , A61K31/19 , A61K31/714 , A23L33/115 , A23L33/00 , A23L33/20 , A23L33/17 , A23L33/12 , A23L33/15 , A23L33/21 , A23L33/19 , A23L33/10
摘要: A method for enhancing cognitive development in a pediatric subject involving administering to the subject a nutritional composition which includes up to 7 g/100 Kcal of a fat or lipid; up to 5 g/100 Kcal of a protein or protein equivalent source; 0.25 g/100 Kcal to 16 g/100 Kcal of buttermilk; 5 mg/100 Kcal to 90 mg/100 Kcal of a source of long chain polyunsaturated fatty acid; and 0.015 g/100 Kcal to 1.5 g/100 Kcal of a prebiotic.
-
公开(公告)号:US20200305469A1
公开(公告)日:2020-10-01
申请号:US16765581
申请日:2018-06-21
摘要: A method for producing a sugar-reduced fruit juice (S), in particular apple juice, wherein components of the fruit (A) are pressed after an at least partial comminution or fractioning process for obtaining the fruit juice. Prior to the pressing process using solely one part (16) of the fruit flesh; at least one part of the juice (14) obtained from the pressed fruit flesh is subjected to an at least partial sugar-removal method (S5); and the juice (15) obtained from the sugar-removal method is combined or mixed with the juice from the pressing process of the rind (11) and optionally the juice (17) from the remaining part of the fruit flesh, whereby the production of a sugar-reduced fruit juice (S) is made possible while retaining as much of the secondary plant contents as possible.
-
公开(公告)号:US10695360B2
公开(公告)日:2020-06-30
申请号:US15898016
申请日:2018-02-15
发明人: Jun Yoshino , Hisataka Yasuda , Hideo Arai , Tetsuro Enomoto
IPC分类号: A61K31/706 , A61P3/04 , A61K9/00 , A61K31/185 , A61K38/06 , A61K31/205 , A61K31/197 , A61K31/122 , A61K31/7012 , A61K31/7004 , A61K36/81 , A61K36/9068 , A61K36/185 , A61K36/77 , A61K36/38 , A61K31/198 , A61K31/165 , A61K31/702 , A23L33/13 , A23K20/153 , A61P3/10 , A61K45/06 , A23L33/20 , A61K8/67
摘要: The present disclosure provides for the administration of β-NMN, which increases the secretion of adiponectin. The present disclosure also provides an adiponectin secretion enhancer comprising β-nicotinamide mononucleotide, a pharmaceutically acceptable salt thereof or a solvate thereof, and a dietary supplement containing the aforementioned secretion enhancer, which can be ingested in order to increase the secretion of adiponectin. Also disclosed are methods of treating insulin resistance-related diseases such as of metabolic syndrome, diabetes, hyperlipidemia, fatty liver disease, hypertension, obesity, and arteriosclerosis.
-
公开(公告)号:US20190327990A1
公开(公告)日:2019-10-31
申请号:US16502204
申请日:2019-07-03
申请人: fairlife, LLC
发明人: Shakeel Ur-Rehman , Brandon Kopesky , Tim Doelman
摘要: Disclosed are processes for producing cultured dairy products, such as yogurt, that are shelf-stable without refrigeration. Such processes can include contacting a milk base having from 0.5 to 1.9 wt. % milk sugar with a lactic acid bacteria culture and aseptically packaging in a container, followed by storage under conditions suitable to result in a pH of less than 4.7.
-
公开(公告)号:US10288612B2
公开(公告)日:2019-05-14
申请号:US15358864
申请日:2016-11-22
IPC分类号: G01N33/569 , A23L33/20 , A61K31/00 , G01N33/68
摘要: Disclosed are methods of diagnosing and treating a subject with active or inactive eosinophilic esophagitis (EoE). The methods may include the steps of detecting whether a level of eosinophil lineage-committed progenitor (EoP) is elevated in a blood sample obtained from a subject, diagnosing the subject with active EoE when an EoP level in the sample is elevated above a pre-determined cut-off value and diagnosing the subject with inactive EoE when the EoP level in the sample is below a pre-determined cut-off value; and treating the subject diagnosed with active EoE. Kits related to same are also disclosed.
-
-
-
-
-
-
-
-
-